MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Delayed Börse Stuttgart 06:59:13 04/06/2024 pm IST | ||
| 0.54 EUR | +3.85% |
|
| Current month | -3.70% | ||
| 1 month | -31.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 04/24/04 | 0.54 | +3.85% |
| 03/24/03 | 0.52 | -3.70% |
| 31/24/31 | 0.54 | +20.00% |
| 30/24/30 | 0.45 | -4.26% |
| 29/24/29 | 0.47 | -20.34% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 06:59 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | ME73R1 |
| ISIN | DE000ME73R11 |
| Date issued | 17/01/2024 |
| Strike | 42.88 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.76 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.06 € |
|---|---|
| Lowest since issue | 0.45 € |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.36
EUR
Average target price
52.64
EUR
Spread / Average Target
+8.85%
- Stock Market
- Certificates
- Certificat
